Ivan C

ORCID: 0000-0002-4848-0168 · 2 papers in corpus

2023

Abstracts of the Annual Meeting of the ”Iuliu Haţieganu” University of Medicine and Pharmacy : 4th – 8th December 2023, Cluj-Napoca

Medicine and pharmacy reports

2019

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.

EBioMedicine ·doi:10.1016/j.ebiom.2018.11.045

BackgroundInflammatory mediator prostaglandin E2-prostaglandin E2 receptor EP3 (PTGER3) signaling is critical for tumor-associated angiogenesis, tumor growth, and chemoresistance. However, the mechanism underlying these effects in ovarian c…